| P50 | author | Norman L. Letvin | Q98917684 |
| P2860 | cites work | Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 |
| | Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 |
| | Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 |
| | Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies | Q29614531 |
| | Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group | Q29614934 |
| | Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 |
| | Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene | Q33196552 |
| | Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques | Q33490720 |
| | Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV | Q33800033 |
| | Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection | Q33809753 |
| | Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination | Q33851802 |
| | HIV-1 sequence variation: drift, shift, and attenuation | Q34175357 |
| | Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. | Q34214455 |
| | CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication | Q34390292 |
| | A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. | Q35870467 |
| | Pathogenic diversity of simian immunodeficiency viruses | Q40692683 |
| | A formalin-inactivated whole SIV vaccine confers protection in macaques | Q42188961 |
| | Recombinant Virus Vaccine-Induced SIV-specific CD8 + Cytotoxic T Lymphocytes | Q42616181 |
| | Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. | Q44022556 |
| | Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease | Q44718436 |
| | Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity | Q45734062 |
| | A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers | Q45748603 |
| | Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up | Q46879617 |
| | Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA | Q56930699 |
| | Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes | Q57075675 |
| | Anti-cell antibody in macaques | Q59098168 |
| | Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination | Q73097737 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15-20 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Strategies for an HIV vaccine | |
| P478 | volume | 110 | |